BTBehnam Tajik

Behnam Tajik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Behnam Tajik has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Relationship Between School-Based Bullying Behaviours and Happiness, and the Mediating Role of Body Mass Index at School-entry: Evidence from the Born in Bradford Primary School Years Study

    by Behnam Tajik, Kate E Pickett, Katharine E Roberts, Maria Bryant

    Background Despite extensive research on school-based bullying and its effects on children’s well-being, the role of body mass index (BMI) as a moderating factor in these dynamics is not fully known. Methods This study aims to assess the relationships between experiencing bullying and being mean to others, and happiness in school-aged children, assessed through self-reported surveys at ages 7–10 years, while evaluating whether BMI at school-entry (measured at ages 4–5 years) influenced these associations. Data were drawn from the Born in Bradford Primary School Years study, a large, ethnically diverse longitudinal cohort study in the UK. Logistic regression models were used to analyse the relationships between school-based bullying involvement/ being mean to others and happiness, and whether these were moderated by BMI at school-entry, to explore potential long-term effects of weight status on social and emotional well-being. Results 51.4% of children reported being bullied (54.7% girls vs. 48.3 boys). Those who were bullied by others had lower odds of feeling happy all the time (OR = 0.60, 95% CI: 0.42–0.86, p = 0.006). This association was observed among those who were mean to others regarding feeling happy all the time (OR = 0.34, 95% CI: 0.24–0.49, p < 0.001) or sometimes happy (OR = 0.20, 95% CI: 0.13–0.30, p < 0.001). Although children with obesity had a slightly higher prevalence of being bullied (52.6%) compared to their healthy-weight peers (48.6%), BMI at school-entry did not modify the relationship between school-based bullying or mean behaviour and happiness. Conclusions The findings of our study highlight the negative impact of school-based bullying on children’s happiness, regardless of BMI at school-entry. Implementing school-based interventions and strengthening social support systems may help mitigate these effects and enhance children’s emotional well-being. Future research in different longitudinal designs is warranted to confirm the long-term interplay between school-based bullying, BMI at school-entry, and psychological outcomes.

  • Open Access

    Associations of the serum n-6 PUFA concentrations with exercise-induced myocardial ischaemia in middle-aged and older men

    by Haleh Esmaili, Behnam Tajik, Tomi-Pekka Tuomainen, Sudhir Kurl, Jukka T. Salonen, Jyrki K. Virtanen

    n-6 PUFA, especially linoleic acid (LA) but also arachidonic acid (AA), have been inversely associated with CHD. However, mechanisms underlying these associations are not fully known. We investigated the associations of the serum concentrations of total n-6 PUFA, LA, AA, γ-linolenic acid (GLA) and dihomo-γ-linolenic acid (DGLA), with the odds of myocardial ischaemia during exercise, a predictor of future cardiac events. A total of 1871 men without a history of CHD from the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD) aged 42–60 years were included. All participants performed a maximal symptom-limited exercise stress test, using an electrically braked bicycle ergometer. Multivariable-adjusted logistic regression was used to assess the OR for exercise-induced myocardial ischaemia in quartiles of the serum n-6 PUFA concentrations. After multivariable adjustment, men in the highest v. the lowest serum AA concentration had 50 % lower odds for exercise-induced myocardial ischaemia (OR 0·50, 95 % CI 0·34, 0·76; P-trend across quartiles < 0·001). For the other PUFA, the OR (95 % CI) were 1·00 (0·69, 1·46; P-trend = 0·89) for LA, 1·07 (0·75, 1·53; P-trend = 0·40) for GLA and 0·74 (0·51, 1·07; P-trend = 0·16) for DGLA. Among the n-6 PUFA, higher serum concentration of AA was associated with lower odds for myocardial ischaemia during an exercise test in middle-aged and older men. This may provide one mechanism for the previously observed possible cardioprotective properties of AA. Our findings also suggest that n-6 PUFA should not be considered as one homogenous group.

  • Open Access

    Frailty Predicts Incident Atrial Fibrillation in Women but Not in Men: The Kuopio Ischaemic Heart Disease Risk Factor Study

    by Behnam Tajik, Ari Voutilainen, Arja Lyytinen, Jussi Kauhanen, Gregory Y. H. Lip, Tomi-Pekka Tuomainen, Masoud Isanejad

    Introduction: Frailty and atrial fibrillation (AF) are common aging problems and increasing globally. The association(s) between frailty and AF has been inconclusive. The purpose of this prospective population-based cohort was to investigate the associations between frailty and incident AF in older men and women. Methods: In total 839 participants, women (n = 458) and men (n = 381), aged 61–74 years from the Kuopio Ischaemic Heart Disease Risk Factor Study were included (March 1, 1998, to December 31, 2001). At the baseline, frailty prevalence was 49.3% (n = 414), and non-frailty 50.7% (n = 425) of the total population. Frailty was ascertained with the presence of 3–5 and prefrailty 1–2 of the following criteria: weight loss (highest 20% over 7 years), self-reported tiredness, weakness (measured by handgrip strength), slow walking speed (walking pace), and low physical activity (lowest 20%). AF events were obtained by record linkages from the national computerized hospitalization registry in Finland up to December 31, 2019. Multivariate Cox proportional hazard regression estimated the hazard ratio (HR) of incident events, adjusted for potential confounders. Results: During the mean follow-up of 14.2 years, 288 AF cases (169 women; 119 men) occurred. After adjustment for possible confounders, the HRs (95% confidence intervals [CIs]) for AF was 1.46 (1.48–1.85) in the frail population, compared to the non-frail group. The association was observed only among older frail women (multivariable-adjusted HR 1.78, 95% CI [1.28–2.48]) (p for interaction = 0.04). No statistically significant associations were observed between frailty and future AF incident among men (multivariable-adjusted HRs 1.12, 95% CI (0.77–1.63)). Conclusions: In this population-based epidemiological cohort, the risk of developing AF was increased in women affected by frailty at baseline but not in men.


  • Population attributable risk fraction of modifiable risk factors associated with poor self-rated health among children and adolescent; the CASPIAN-V study

    by Ibrahim Abdollahpour, Yahya Salimi, Behnam Tajik, Mostafa Qorbani, Maryam Yazdi, Haleh Esmaili, Majid Khademian, Mohammad Esmaeil Motlagh, Roya Kelishadi

  • Open Access

    Frailty Alone and Interactively with Obesity Predicts Heart Failure: Kuopio Ischaemic Heart Disease Risk Factor Study

    by Behnam Tajik, Ari Voutilainen, Rajiv Sankaranarayanan, Arja Lyytinen, Jussi Kauhanen, Gregory Y.H. Lip, Tomi-Pekka Tuomainen, Masoud Isanejad

    Aims: We aim to evaluate the association of frailty and high body mass index with risk of incident heart failure. Methods and results: From the Kuopio Ischaemic Heart Disease Risk Factor Study, 408 women and 369 men, aged 61–74 years were included in this study. Frailty was ascertained with the presence of 3–5 and prefrailty 1–2 of the following criteria: weight loss (highest 20% over 7 years), self-reported tiredness, weakness (measured by handgrip strength), slow walking speed (walking pace), and low physical activity (lowest 20%). At the baseline, participants were allocated to frail (n = 36), prefrail (n = 340), and robust (n = 441). HF incidents were obtained by record linkages from the national hospitalization registry in Finland up to 31 December 2019. Multivariate Cox proportional hazards regression estimated the hazard ratio (HR) of incident events, adjusted for potential confounders. Two hundred one HF events were recorded (111 in women and 90 in men) during the 14.2 years follow-up. After adjustment for the age and sex, the risk of HF events was higher among prefrail (HR 1.42, 95% CI 1.08 to 1.79, P = 0.02) and frail (HR 3.39, 95% CI 1.89 to 4.79, P ≤ 0.001) compared with the robust group. After adjusting for multiple confounders result remained significant for HF indecent in prefrail [1.46 (HR 1.46, 95% CI 1.09 to 1.95, P = 0.01] and frail (HR 3.33, 95% CI 1.86 to 5.70, P ≤ 0.001). In the sensitivity analysis, significant interaction between high BMI (≥25 kg/m2) and frailty was observed (P for interaction = 0.02). The association of frailty [multivariate-adjusted HR: 2.88 (1.56 to 5.33), P ≤ 0.001)] and prefrailty [multivariate-adjusted HR: 1.40 (1.08 to 1.91), P = 0.03)] with risk of HF indecent was more pronounced in those with high BMI. Conclusions: Frailty is highly common in older age, and our results indicated the high risk of HF incident in frail and prefrail groups. While frailty is clinically recognized by weight loss phenotype, our finding showed that frailly and high BMI can coexist and worsen the risk of HF incidence. Further research is warranted to substantiate these results in large studies and clinical settings.


  • Open Access

    Associations of the serumn-6 PUFA with exercise cardiac power in men

    by Haleh Esmaili, Behnam Tajik, Tomi-Pekka Tuomainen, Sudhir Kurl, Jukka T. Salonen, Jyrki K. Virtanen

    Low intake or tissue concentrations of the n-6 polyunsaturated fatty acids (PUFA), especially to the major n-6 PUFA linoleic acid (LA), and low exercise cardiac power (ECP) are both associated with cardiovascular disease risk. However, associations of the n-6 PUFAs with ECP are unknown. The aim of the present study was to explore cross-sectional associations of the serum total n-6 PUFA, LA, arachidonic acid (AA), γ-linolenic acid (GLA) and dihomo-γ–linolenic acid (DGLA) concentrations with ECP and its components. In total, 1685 men aged 42-60 years from the Kuopio Ischaemic Heart Disease Risk Factor Study and free of cardiovascular diseases were included. Analysis of covariance was used to examine the mean values of ECP (maximal oxygen uptake (VO2max)/maximal systolic blood pressure (SBP)) and its components in quartiles of the serum total and individual n-6 PUFA concentrations. After multivariable adjustments, higher serum total n-6 PUFA concentration was associated with higher ECP and VO2max [for ECP, the extreme-quartile difference was 0.77 mL/mmHg (95%CI 0.38-1.16, P-trend across quartiles <0.001) and for VO2max 157 mL/min (95%CI 85-230, P-trend<0.001)], but not with maximal SBP. Similar associations were observed with serum LA concentration. Higher serum AA concentration was associated with higher ECP but not with VO2max or maximal SBP. The minor serum n-6 PUFAs GLA and DGLA were associated with higher maximal SBP during exercise test and DGLA also with higher VO2max but neither with ECP. In conclusion, especially LA concentration was associated with higher ECP. This may provide one mechanism for the cardioprotective properties of especially LA.


  • Open Access

    Exercise and Nutritional Interventions on Sarcopenia and Frailty in Heart Failure: A Narrative Review of Systematic Reviews and Meta-Analyses

    by Konstantinos Prokopidis, Masoud Isanejad, Asangaedem Akpan, Maria Stefil, Behnam Tajik, Panagiotis Giannos, Massimo Venturelli, Rajiv Sankaranarayanan

    The purpose of this review is to describe the present evidence for exercise and nutritional interventions as potential contributors in the treatment of sarcopenia and frailty (i.e. muscle mass and physical function decline) and the risk of cardiorenal metabolic comorbidity in people with heart failure (HF). Evidence primarily from cross-sectional studies suggests that the prevalence of sarcopenia in people with HF is 37% for men and 33% for women, which contributes to cardiac cachexia, frailty, lower quality of life, and increased mortality rate. We explored the impact of resistance and aerobic exercise, and nutrition on measures of sarcopenia and frailty, and quality of life following the assessment of 35 systematic reviews and meta-analyses. The majority of clinical trials have focused on resistance, aerobic, and concurrent exercise to counteract the progressive loss of muscle mass and strength in people with HF, while promising effects have also been shown via utilization of vitamin D and iron supplementation by reducing tumour necrosis factor-alpha (TNF-a), c-reactive protein (CRP), and interleukin-6 (IL-6) levels. Experimental studies combining the concomitant effect of exercise and nutrition on measures of sarcopenia and frailty in people with HF are scarce. There is a pressing need for further research and well-designed clinical trials incorporating the anabolic and anti-catabolic effects of concurrent exercise and nutrition strategies in people with HF.


  • Open Access

    Effects of whey and soy protein supplementation on inflammatory cytokines in older adults: a systematic review and meta-analysis

    by Konstantinos Prokopidis, Mohsen Mazidi, Rajiv Sankaranarayanan, Behnam Tajik, Anne McArdle, Masoud Isanejad

    Background and aims: Low-grade inflammation is a mediator of muscle proteostasis. This study aimed to investigate the effects of isolated whey and soy proteins on inflammatory markers.Methods: We conducted a systematic literature search of randomised controlled trials (RCT) through MEDLINE, Web of Science, Scopus and Cochrane Library databases from inception until September 2021. To determine the effectiveness of isolated proteins on circulating levels of C-reactive protein (CRP), IL-6 and TNF-α, a meta-analysis using a random-effects model was used to calculate the pooled effects (CRD42021252603).Results: Thirty-one RCT met the inclusion criteria and were included in the systematic review and meta-analysis. A significant reduction of circulating IL-6 levels following whey protein [Mean Difference (MD): −0·79, 95 % CI: −1·15, −0·42, I2 = 96 %] and TNF-α levels following soy protein supplementation (MD: −0·16, 95 % CI: −0·26, −0·05, I2 = 68 %) was observed. The addition of soy isoflavones exerted a further decline in circulating TNF-α levels (MD: −0·20, 95 % CI: −0·31, −0·08, I2 = 34 %). According to subgroup analysis, whey protein led to a statistically significant decrease in circulating IL-6 levels in individuals with sarcopenia and pre-frailty (MD: −0·98, 95 % CI: −1·56, −0·39, I2 = 0 %). These findings may be dependent on participant characteristics and treatment duration.Conclusions: These data support that whey and soy protein supplementation elicit anti-inflammatory effects by reducing circulating IL-6 and TNF-α levels, respectively. This effect may be enhanced by soy isoflavones and may be more prominent in individuals with sarcopenia.


  • Open Access

    Lipid levels, apolipoproteins, and risk of incident atrial fibrillation in men: A report from the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD)

    by Behnam Tajik, Tomi-Pekka Tuomainen, Rand Jarroch, Jussi Kauhanen, Gregory Y.H. Lip, Masoud Isanejad


  • Open Access

    The Impact of Frailty and Comorbidities on Heart Failure Outcomes

    by Thomas Salmon, Hani Essa, Behnam Tajik, Masoud Isanejad, Asangaedem Akpan, Rajiv Sankaranarayanan

    Frailty is a multisystemic process leading to reduction of physiological reserve and a reduction in physical activity. Heart failure (HF) is recognised as a global cause of morbidity and mortality, increasing in prevalence over recent decades. Because of shared phenotypes and comorbidities, there is significant overlap and a bidirectional relationship, with frail patients being at increased risk of developing HF and vice versa. Despite this, frailty is not routinely assessed in patients with HF. Identification of these patients to direct multidisciplinary care is key, and the development of a frailty assessment tool validated in a large HF population is also an unmet need that would be of considerable benefit in directing multidisciplinary-team management. Non-pharmacological treatment should be included, as exercise and physical rehabilitation programmes offer dual benefit in frail HF patients, by treating both conditions simultaneously. The evidence for nutritional supplementation is mixed, but there is evidence that a personalised approach to nutritional support in frail HF patients can improve outcomes.